BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26337905)

  • 1. Proton pump inhibitors for the treatment of cancer in companion animals.
    Walsh M; Fais S; Spugnini EP; Harguindey S; Abu Izneid T; Scacco L; Williams P; Allegrucci C; Rauch C; Omran Z
    J Exp Clin Cancer Res; 2015 Sep; 34(1):93. PubMed ID: 26337905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning of proton pump inhibitors in cancer therapy.
    Lu ZN; Tian B; Guo XL
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):925-937. PubMed ID: 28861639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.
    Spugnini EP; Baldi A; Buglioni S; Carocci F; de Bazzichini GM; Betti G; Pantaleo I; Menicagli F; Citro G; Fais S
    J Transl Med; 2011 Dec; 9():221. PubMed ID: 22204495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
    Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S
    J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors may reduce tumour resistance.
    De Milito A; Fais S
    Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of clinical trials in veterinary oncology.
    Burton J; Khanna C
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors.
    Spugnini EP; Fais S
    Expert Opin Ther Pat; 2020 Jan; 30(1):15-25. PubMed ID: 31847622
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for the use of proton pump inhibitors as antineoplastic agents.
    De Milito A; Marino ML; Fais S
    Curr Pharm Des; 2012; 18(10):1395-406. PubMed ID: 22360553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
    Zabielska-KoczywÄ…s K; Lechowski R
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29215573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving human cancer therapy through the evaluation of pet dogs.
    LeBlanc AK; Mazcko CN
    Nat Rev Cancer; 2020 Dec; 20(12):727-742. PubMed ID: 32934365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity.
    Vail DM
    Top Companion Anim Med; 2009 Aug; 24(3):122-9. PubMed ID: 19732730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular acidity as favouring factor of tumor progression and metastatic dissemination.
    Calorini L; Peppicelli S; Bianchini F
    Exp Oncol; 2012 Jul; 34(2):79-84. PubMed ID: 23013757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology.
    Di Cerbo A; Palmieri B; De Vico G; Iannitti T
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1807-14. PubMed ID: 24816783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemotherapy in Veterinary Oncology: State-of-the-Art and Perspectives.
    Spugnini EP; Baldi A
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):967-979. PubMed ID: 31176458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking on cancer: treatment increases, improves for companion animals.
    Burns K
    J Am Vet Med Assoc; 2014 Jan; 244(2):140-4. PubMed ID: 24378021
    [No Abstract]   [Full Text] [Related]  

  • 20. Veterinary photodynamic therapy: a review.
    Buchholz J; Walt H
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):342-7. PubMed ID: 24284083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.